Potential role for dihydrotachysterol2 metabolites and pamidronate in the management of renal bone disease

Potential role for dihydrotachysterol2 metabolites and pamidronate in the management of renal bone disease

Bibliographic Details
Main Author:	Fan, Stanley Lin-sun
Published:	University of Cambridge 2010
Subjects:	610
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608763

Similar Items

The D Vitamins and Dihydrotachysterol in Metabolic Diseases
by: C E Dent
Published: (2003-01-01)

Effect of Pamidronate on Bone Pain in Patients with Bone Metastasis
by: Shahrbanoo Keihanian, et al.
Published: (2013-06-01)

Studies of bone disease in chronic renal failure
by: Henderson, R. G.
Published: (1980)

Hepatic Osteodystrophy: The Mechanism of Bone Loss in Hepatocellular Disease and the Effects of Pamidronate Treatment
by: Adriano L. Spirlandeli, et al.

The role of phytomolecules in the prevention of bone cell apoptosis : potential role in bone health
by: Ali, Faizaa
Published: (2018)

In silico investigations of the anti-catabolic effects of pamidronate and denosumab on multiple myeloma-induced bone disease.
by: Yan Wang, et al.
Published: (2012-01-01)

The role of arachidonic acid metabolites in inflammatory bowel disease
by: Boughton-Smith, N. K.
Published: (1986)

Comparison of the effect of alendronate and pamidronate on bone density of patients with osteoporosis
by: Zohre Nobakht, et al.
Published: (2018-12-01)

Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors
by: Jackie M. Wypij, et al.
Published: (2014-01-01)

The potential role of a carboxypeptidase B2 inhibitor in renal fibrosis
by: Oguntona, Taiwo Shola
Published: (2018)

Preparation and Biodistribution of 99mTc-Pamidronate as Bone Imaging Agent
by: LUO Hong-yi, et al.
Published: (2016-02-01)

Use of disodium pamidronate bisphosphonate in patients with bone metastases of lung cancer
by: Ranković Boško, et al.
Published: (2002-01-01)

Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
by: Se Won Lim, et al.
Published: (2016-03-01)

The presence of pamidronate in bone cement affects serum biochemical markers in the rat
by: Matuszewski Łukasz, et al.
Published: (2014-06-01)

The use of dihydroxylated metabolites of vitamin Dsub(3) in the treatment of renal osteodystrophy
by: Muirhead, N.
Published: (1983)

Effectiveness of the treatment with intravenous pamidronate in children with rheumatic diseases
by: Marco A, et al.
Published: (2008-09-01)

An analytical study of the role of selected metal ions in bone and joint diseases
by: Furst, Alexandra
Published: (1995)

The role of the bone mineral axis in non-uraemic vascular disease
by: Ellam, Timothy
Published: (2014)

Reactive oxygen metabolites and inflammatory bowel disease
by: Simmonds, Nicola Jane
Published: (1992)

Intravenous pamidronate for refractory rheumatoid arthritis
by: Mansour Salesi, et al.
Published: (2012-01-01)

Therapy with pamidronate in children with osteogenesis imperfecta
by: Marginean O, et al.
Published: (2017-08-01)

The role of systematic reviews in determining best practice in the management of end-stage renal disease
by: Daly, Conal
Published: (1998)

Selenium-Substituted Hydroxyapatite/Biodegradable Polymer/Pamidronate Combined Scaffold for the Therapy of Bone Tumour
by: Ewa Oledzka, et al.
Published: (2015-09-01)

Determination of Pamidronate in Bisphosphonate-Enriched Bone Cement by Ion-Pair Hplc and Capillary Electrophoresis
by: Matuszewski Łukasz, et al.
Published: (2013-06-01)

The role of local complement factor H production in complement-mediated renal disease
by: Vernon, Katherine Anne
Published: (2013)

Time course of changes in bone resorption markers during pamidronate therapy in breast cancer patients with bone metastases
by: A. D. Petrova, et al.
Published: (2014-07-01)

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008-10-01)

Renal functional reserve and hypertension in renal diseases
by: Mansy, Hatem
Published: (1990)

Pamidronate “zebra lines”: A treatment timeline
by: Avgi Loizidou, BSc, MBChB, et al.
Published: (2017-12-01)

Transglutaminase 2 in chronic kidney disease of the domestic feline and its role in a rodent model of renal warm ischaemia
by: Sánchez Lara, Armando Cristian
Published: (2015)

Vascular endothelial growth factor : an investigation of assay techniques and conditions and an investigation of a potential role for VEGF in the pathogenesis of proteinuria in paediatric and adult renal disease
by: Webb, Nicholas J. A.
Published: (1998)

Studies on Role of Arachidonic Acid Metabolites and Mechanism of Their Formation during Activation of Human Platelets
by: Moriyama, Tatsuya
Published: (2013)

Caisson disease of bone : an experimental study of its cause, early diagnosis, and management
by: Stothard, John
Published: (1981)

Indoles as gut microbial pharmaco-metabolites : targets, mechanisms and consequences for obesity and cardiometabolic diseases
by: Fernandes Neves Soares, Ana Luísa
Published: (2017)

Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta
by: Chia-Hsuan Lin, et al.
Published: (2014-08-01)

Preparation, Characterization, and Radiolabeling of [<sup>68</sup>Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent
by: Zarif Ashhar, et al.
Published: (2020-06-01)

Immune regulation in renal disease
by: Salama, Alan David
Published: (2001)

Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.
by: Zijie Wang, et al.
Published: (2014-01-01)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
by: F.A. Pereira, et al.
Published: (2012-12-01)

Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats
by: F.A. Pereira, et al.
Published: (2012-12-01)

Cannot write session to /tmp/vufind_sessions/sess_elm6amq1q3730e4r8fupq6g6re